• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

EOA accepting applications for technology grants

Article

Essilor of America Inc. (EOA) is now accepting applications for the 2007 Essilor Optical Technology Grants. The grants will be awarded to schools and colleges that demonstrate a commitment to growing the optical industry through new advancements and technology.

Dallas-Essilor of America Inc. (EOA) is now accepting applications for the 2007 Essilor Optical Technology Grants. The grants will be awarded to schools and colleges that demonstrate a commitment to growing the optical industry through new advancements and technology.

Applicants must submit an essay of 1,000 words or less describing why the prospective institution needs and deserves the grant.

All applications will be judged on the school's commitment to the growth of premium optical technology, as well as how the funding will enable the school to elevate its standards and the visibility of ophthalmic dispensing for students and patients.

Applications are available by contacting Danne Ventura at dventura@essilor.com
. All applications must be signed by and accompanied by a letter from the dean or president of the school. Only one application per school may be submitted. Completed applications should be sent to the attention of Danne Ventura by e-mail or by conventional mail at Essilor Lenses, 13555 North Stemmons Freeway, Dallas, TX 75234.

Deadline for submitting an application electronically-on CD-ROM or by e-mail-is Nov. 1. Essilor will announce the recipients on Dec. 1.

Related Videos
Paul Badawi, co-founder and CEO of Sight Sciences, chats with Neda Shamie, MD, about what drives him
© 2024 MJH Life Sciences

All rights reserved.